1. What is the GERD ETF?

The GERD ETF, issued by Legal & General Investment Management (LGIM), tracks the Solactive Gerd Kommer Multifactor Equity Index. This index encompasses equities from both developed and emerging markets worldwide, employing a multifactor weighting strategy designed to deliver stable, long-term investment returns.

2. GERD ETF’s Multifactor Investment Strategy

The GERD ETF’s investment approach integrates five key factors:

• Size: Prioritizes companies with larger market capitalization.
• Value: Selects stocks trading at lower valuations, focusing on value investing.
• Quality: Targets companies with strong profitability and sound financial health.
• Investment: Evaluates companies with significant capital expenditure and asset growth.
• Momentum: Invests in stocks demonstrating strong recent performance.

This multifactor composition is designed to reduce the risk associated with any single factor and to enhance long-term return potential.

3. Latest Price Movements of the GERD ETF

As of September 3, 2025, the GERD ETF was priced at €12.20, representing a 0.64% increase from the previous trading day. Over the past year, the ETF’s price reached a high of €12.30 and a low of €10.51, demonstrating overall stable performance.

4. How Can Investors Utilize the GERD ETF?

For those seeking global portfolio diversification, the GERD ETF offers a cost-effective, transparent solution that aligns with ESG standards. Its accumulating distribution model is tailored for long-term investors, and its 0.50% management fee is competitive within its ETF peer group.